Sodium-dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L-ascorbic acid into schwann cells

GLIA

Volumn 58, Issue 3, 2010, Pages 287-299

  Gess, Burkhard ^a,b   Lohmann, Christina ^a   Halfter, Hartmut ^a   Young, Peter ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b IZKF Muenster ^*  (Germany)

Author keywords

Ascorbic acid; PNS; Schwann cells; SVCT; Vitamin C

Indexed keywords

CALCIUM ION; CARRIER PROTEIN; MAGNESIUM ION; MYELIN; PHLORETIN; SODIUM DEPENDENT VITAMIN C TRANSPORTER 1; SODIUM DEPENDENT VITAMIN C TRANSPORTER 2; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMYELINATION; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MICHAELIS MENTEN KINETICS; MOUSE; NERVE CELL MEMBRANE; NERVE FIBER; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCHWANN CELL; TRANSPORT KINETICS;

ANIMALS; ASCORBIC ACID; BIOLOGICAL TRANSPORT, ACTIVE; CARBON RADIOISOTOPES; CELLS, CULTURED; EXTRACELLULAR FLUID; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MYELIN SHEATH; NERVE FIBERS, MYELINATED; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PERIPHERAL NERVOUS SYSTEM; PHLORETIN; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCHWANN CELLS; SCIATIC NERVE; SYMPORTERS;

EID: 75849122805     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20923     Document Type: Article

References (56)

1. Angelow S, Haselbach M, Galla HJ. 2003. Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroid plexus cells. Brain Res 988:105-113.
2. Berger P, Niemann A, Suter U. 2006. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-tooth disease). Glia 54:243-257.
3. Best KA, Holmes ME, Samson SE, Mwanjewe J, Wilson JX, Dixon SJ, Grover AK. 2005. Ascorbate uptake in pig coronary artery endothelial cells. Mol Cell Biochem 271:43-49.
4. Bornstein SR, Yoshida-Hiroi M, Sotiriou S, Levine M, Hartwig HG, Nussbaum RL, Eisenhofer G. 2003. Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2). FASEB J 17:1928-1930.
5. Burns J, Ouvrier RA, Yiu EM, Joseph PD, Kornberg AJ, Fahey MC, Ryan MM. 2009. Ascorbic acid for Charcot-Marie-tooth disease type 1A in children: A randomized, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol 8:537-544.
6. +-dependent L-ascorbic acid transporter SVCT2 expressed in brain stem cells, neurons and neuroblastoma cells is inhibited by flavonoids. J Neurochem 108:563-577.
7. Carey DJ, Todd MS. 1987. Schwann cell myelination in a chemically defined medium: Demonstration of a requirement for additives that promote Schwann cell extracellular matrix formation. Brain Res 429:95-102.
8. Castro M, Caprile T, Astuya A, Millan C, Reinicke K, Vera JC, Vasquez O, Aguayo LG, Nualart F. 2001. High-affinity sodium-vitamin C cotransporters (SVCT) expression in embryonic mouse neurons. J Neurochem 78:815-823.
9. Dhariwal KR, Hartzell WO, Levine M. 1991. Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 54:712-716.
10. Dyck PJ, Griffin JW, Low PA. 1993. Peripheral neuropathy. Philadelphia: Saunders.
11. Eckersley L. 2002. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol 50:293-321.
12. Eldridge CF, Bunge MB, Bunge RP. 1989. Differentiation of axonrelated Schwann cells in vitro. II. Control of myelin formation by basal lamina. J Neurosci 9:625-638.
13. Eldridge CF, Bunge MB, Bunge RP, Wood PM. 1987. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol 105:1023-1034.
14. Fannon AM, Sherman DL, Ilyina-Gragerova G, Brophy PJ, Friedrich VL Jr, Colman DR. 1995. Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 129:189-202.
15. Fischer H, Schwarzer C, Illek B. 2004. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 101:3691-3696.
16. Garcia Mde L, Salazar K, Millan C, Rodriguez F, Montecinos H, Caprile T, Silva C, Cortes C, Reinicke K, Vera JC, Aguayo LG, Olate J, Molina B, Nualart F. 2005. Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells. Glia 50:32-47.
17. Gess B, Halfter H, Kleffner I, Monje P, Athauda G, Wood PM, Young P, Wanner IB. 2008. Inhibition of N-cadherin and β-catenin function reduces axon-induced Schwann cell proliferation. J Neurosci Res 86:797-812.
18. Godoy A, Ormazabal V, Moraga-Cid G, Zuniga FA, Sotomayor P, Barra V, Vasquez O, Montecinos V, Mardones L, Guzman C, Villigran M, Aguayo LG, Onate SA, Reyes AM, Carcamo JG, Rivas CI, Vera JC. 2007. Mechanistic insights and functional determinants of the transport cycle of the ascorbic acid transporter SVCT2. Activation by sodium and absolute dependence on bivalent cations. J Biol Chem 282:615-624.
19. Hall SM. 1978. The Schwann cell: A reappraisal of its role in the peripheral nervous system. Neuropathol Appl Neurobiol 4:165-176.
20. Jessen KR, Mirsky R. 2002. Signals that determine Schwann cell identity. J Anat 200:367-376.
21. Jessen KR, Mirsky R, Morgan L. 1991. Role of cyclic AMP, proliferation controls in Schwann cell differentiation. Ann NY Acad Sci 633:78-89.
22. Karaczyn A, Ivanov S, Reynolds M, Zhitkovich A, Kasprzak KS, Salnikow K. 2006. Ascorbate depletion mediates up-regulation of hypoxiaassociated proteins by cell density and nickel. J Cell Biochem 97:1025-1035.
23. Kashiba M, Oka J, Ichikawa R, Kasahara E, Inayama T, Kageyama A, Kageyama H, Osaka T, Umegaki K, Matsumoto A, Ishikawa T, Nishikimi M, Inoue M, Inoue S. 2002. Impaired ascorbic acid metabolism in streptozotocin-induced diabetic rats. Free Radic Biol Med 33:1221-1230.
24. Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontes M. 2007. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul Disord 17:248-253.
25. Kaya F, Belin S, Diamantidis G, Fontes M. 2008. Ascorbic acid is a regulator of the intracellular cAMP concentration: Old molecule, new functions? FEBS Lett 582:3614-3618.
26. Korcok J, Yan R, Siushansian R, Dixon SJ, Wilson JX. 2000. Sodiumascorbate cotransport controls intracellular ascorbate concentration in primary astrocyte cultures expressing the SVCT2 transporter. Brain Res 881:144-151.
27. Kuhlenbäumer G, Stögbauer F, Young P, Ringelstein EB. 2005. Hereditary peripheral neuropathies. Darmstadt: Steinkopff-Verlag.264 p.
28. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. 1996. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 93:3704-3709.
29. Liang WJ, Johnson D, Jarvis SM. 2001. Vitamin C transport systems of mammalian cells. Mol Membr Biol 18:87-95.
30. Lindsay RM, Jamieson NS, Walker SA, McGuigan CC, Smith W, Baird JD. 1998. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes. Diabetologia 41:516-523.
31. Maier M, Berger P, Nave KA, Suter U. 2002. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol Cell Neurosci 20:93-109.
32. Maier M, Castagner F, Berger P, Suter U. 2003. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons. Mol Cell Neurosci 24:803-817.
33. May JM, Li L, Hayslett K, Qu ZC. 2006. Ascorbate transport and recycling by SH-SY5Y neuroblastoma cells: Response to glutamate toxicity. Neurochem Res 31:785-794.
34. Monje PV, Rendon S, Athauda G, Bates M, Wood PM, Bunge MB. 2009. Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell re-differentiation. Glia 57:947-961.
35. Nave KA, Salzer JL. 2006. Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol 16:492-500.
36. Pareyson D, Schenone A, Fabrizi GM, Santoro L, Padua L, Quattrone A, Vita G, Gemignani F, Visioli F, Solari A. 2006. A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMTTRIAAL): The study protocol [EudraCT no.: 2006-000032-27]. Pharmacol Res 54:436-441.
37. Parkinson DB, Dickinson S, Bhaskaran A, Kinsella MT, Brophy PJ, Sherman DL, Sharghi-Namini S, Duran Alonso MB, Mirsky R, Jessen KR. 2003. Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells. Mol Cell Neurosci 23:13-27.
38. Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontes M. 2004. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 10:396-401.
39. Qiao H, May JM. 2008. Development of ascorbate transporters in brain cortical capillary endothelial cells in culture. Brain Res 1208:79-86.
40. Qiu S, Li L, Weeber EJ, May JM. 2007. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res 85:1046-1056.
41. Richardson JK. 2005. Optimizing gait in peripheral neuropathy. In: Hausdorff JM, Alexander NB, editors. Gait disorders. New York: Informa Health Care. pp 339-355.
42. Savini I, Rossi A, Pierro C, Avigliano L, Catani MV. 2008. SVCT1 and SVCT2: Key proteins for vitamin C uptake. Amino Acids 34:347-355.
43. Scherer SS. 1997. The biology and pathobiology of Schwann cells. Curr Opin Neurol 10:386-397.
44. Scherer SS. 1999. Nodes, paranodes, and incisures: From form to function. Ann NY Acad Sci 883:131-142.
45. Sotiriou S, Gispert S, Cheng J, Wang Y, Chen A, Hoogstraten-Miller S, Miller GF, Kwon O, Levine M, Guttentag SH, Nussbaum RL. 2002. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med 8:514-517.
46. Suter U, Snipes GJ. 1995. Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 18:45-75.
47. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI. 1994. Regulation of tissuespecific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 269:25795-25808.
48. Takanaga H, Mackenzie B, Hediger MA. 2004. Sodium-dependent ascorbic acid transporter family SLC23. Pflugers Arch 447:677-682.
49. Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, Wang Y, Brubaker RF, Hediger MA. 1999. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 399:70-75.
50. Vroemen M, Weidner N. 2003. Purification of Schwann cells by selection of p75 low affinity nerve growth factor receptor expressing cells from adult peripheral nerve. 124:135-143.
51. Wang Y, Mackenzie B, Tsukaguchi H, Weremowicz S, Morton CC, Hediger MA. 2000. Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun 267:488-494.
52. Wilson JX. 2005. Regulation of vitamin C transport. Annu Rev Nutr 25:105-125.
53. Young P, Boussadia O, Berger P, Leone DP, Charnay P, Kemler R, Suter U. 2002. E-cadherin is required for the correct formation of autotypic adherens junctions of the outer mesaxon but not for the integrity of myelinated fibers of peripheral nerves. Mol Cell Neurosci 21:341-351.
54. Young P, De Jonghe P, Stogbauer F, Butterfass-Bahloul T. 2008. Treatment for Charcot-Marie-tooth disease. Cochrane Database Syst Rev DOI: 10.1002/14651858.CD006052.pub2.
55. Young P, Suter U. 2001. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-tooth disease. Brain Res Brain Res Rev 36:213-221.
56. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. 1996. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 8:129-145.